Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.
Among those against the idea, the most common reason is loss of competitiveness for U.S. companies.
U.S. public company board members’ optimism dropped at the end of Q2 amid fears that inflation will hamper growth in 2022.
U.S. public company board members are increasingly confident about the future for business, betting on low interest rates and the unleashing of consumer demand following a successful vaccine rollout.
Vaccines, consumer behavior and pent-up demand fuel optimism in America’s boardrooms.
12Page 1 of 2